Close
Advanced Search

The editorial cited below1 incorrectly identified nisoldipine as the dihydropyridine calcium antagonist used in the Syst-Eur trial. The correct drug is nitrendipine. In addition, Dr. Fagard's name was incorrectly spelled in reference 9.

References

1.
Materson
BJ
:
Prospective, double-blind, seemingly ignored clinical trials
.
Am J Hypertens
 
1999
;
12
:
76
–
78
.
Google Scholar
PubMed
 
© 1999 by the American Journal of Hypertension, Ltd.
American Journal of Hypertension, Ltd.
Issue Section:
Errata
Download all figures